Skip directly to site content Skip directly to search


Español  Other Languages


An official website of the United States government Here's how you know
 Official icon**Official websites use .gov**
				A .gov website belongs to an official government organization in the United States. Lock icon**Secure .gov websites use HTTPS**
				A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
	CDC LogoCDC Logo
 Search

		×
			NIOSH
			NIOSH

				All CDC
				Submit


The National Institute for Occupational Safety and Health (NIOSH)





Current Intelligence Bulletin 9: Chloroform (DDM)						Print
																Related Pages
										March 15, 1976
DHHS (NIOSH) Publication Number 78-127
Department of Health, Education, and Welfare
Public Health Service
Center for Disease Control
National Institute for Occupational Safety and Health
5600 Fishers Lane
Rockville, Maryland 20852
The enclosed background material an chloroform has been prepared by the Office of Extramural Coordination and Special Projects, National Institute for Occupational Safety and Health, to alert members of the occupational health community to new information on a potential occupational hazard.
Your comments and suggestions for changes to future reports are solicited.
Sincerely yours,*[signature]*
John F. Finklea, M.D.
Director
Summary
Chloroform has been shown to be carcinogenic by ingestion in laboratory mice and rats, according to a report recently released by the National Cancer Institute. Because of the uses of chloroform in the work environment and the potential for cancer induction in humans, the National Institute for Occupational Safety and Health (NIOSH) is alerting the occupational health community as part of its Current Intelligence System. In addition, NIOSH is attempting to identify a worker population at risk of chloroform exposures for epidemiologic study.
Introduction
On March 1, 1976, the National Cancer Institute released its report on the carcinogenic bioassay of chloroform.1 According to this report, chloroform ingestion produced malignant kidney tumors in rats and hepatocellular carcinoma in mice.
Background
Chloroform is a colorless volatile liquid, has a normal boiling point of 61°C, and is miscible with the principal organic solvents. Chloroform is manufactured by the chlorination of methane in a process which can be made to yield varying proportions of methyl chloride, methylene chloride, chloroform, and carbon tetrachloride. A list of domestic manufacturers and producers of chloroform is presented in Table 1 and the domestic distributors of chloroform are listed in Table 2.
During 1974, 302 million pounds of chloroform were produced in the United States. Domestic sales for the same year were 252 million pounds.3
Most of the chloroform produced is consumed as a raw material in the preparation of fluorocarbons. [Fluorocarbons are used as aerosol propellants, refrigerants, and blowing agents as well as in the manufacture of fluorocarbon resins such as polytetrafluoroethylene].
Other applications5 of chloroform have included use in the extraction and purification of penicillin and other antibiotics, in the purification of alkaloids, in the solvent extraction of vitamins and flavors, as a general solvent, as an intermediate in the preparation of dyes, drugs, and pesticides, and as an anesthetic. Chloroform is currently found in cough and cold preparations, dental preparations (tooth-ache drops, toothpastes, mouthwashes) and topical liniments. Chloroform would be found in most chemistry laboratories.
Toxicity
Human
Chloroform was first used as an anesthetic in 1847. Its narcotic effects on the central nervous system have been well-documented.6,7,8 Toxic hepatitis has been reported among chemical workers exposed to chloroform9 and, in addition, cardiac irregularities during anesthesia, and local irritation when applied to skin, have also been reported.10
Two epidemiologic studies of occupational exposure to chloroform found episodes of lassitude, dry mouth, depression, irritability and painful urination.9,11
To date, there have been no published reports of any association between chloroform and cancer in humans.
Animal
Depression of the central nervous system has been seen in a number of animal studies of effects of chloroform inhalation.12 Inhalation of chloroform also produces dilation of pupils of the eyes, reduced reaction to light, and reduced intraocular pressure. Fatty degeneration and necrosis of the liver as well as kidney impairment have been seen in experimental animals after ingestion, inhalation, and intravenous administration.13
Carcinogenic effects of chloroform in laboratory animals have been reported in two published studies. Eschenbrenner, in 1945, produced hepatomas in 7 of 10 female mice fed 30 doses at 4-day intervals of approximately 600 to 1200 mg/kg/dose over a four-month period. The other three female mice died within the first week of the experiment. Male mice receiving similar doses also died within the first week.14
In the recent National Cancer Institute study, Osborne-Mendel rats were fed chloroform in corn oil (at 90 and 180 mg/kg body weight for males and at 100 and 200 mg/kg for females) for 111 weeks. A significant increase in epithelial tumors of the kidney in treated male rats was observed. Of the 13 tumors of renal tubular cell epithelium observed in 12 of the 50 high dose male rats, ten were carcinomas and three adenomas; two of the carcinomas were found to have metastasized. Two carcinomas and two adenomas of renal tubular epithelium were observed among the 50 low dose male rats. The tubular cell adenocarcinoma widely metastasized. An increase in thyroid tumors in chloroform-treated female rats was also seen; however, NCI does not consider these to be significant findings.
Mice (B6C3F) were fed chloroform for 92-93 weeks at 138 and 277 mg/kg doses for males and at 238 and 477 mg/kg doses for females. A highly significant increase in hepatocellular carcinomas was observed in both sexes of treated mice when compared with control animals. The incidence of hepatocellular carcinoma was 98% for males and 95% for females at the high dose, and 36% for males and 80% for females at the low dose compared with 6% in both matched and colony control males, none in matched control females, and 1% in colony control females. Nodular hyperplasia of the liver was observed in many low dose male mice that had not developed hepatocellular carcinoma.
Occupational Exposure
The National Institute for Occupational Safety and Health estimates that 40,000 persons are exposed occupationally to chloroform. The majority of these are workers in industries where chloroform is used in small amounts. These industries include those producing biological products, pharmaceutical preparations, paint and allied products, and surgical supplies, as well as hospitals, paper milling, petroleum refining and metal industries.
The current Occupational Safety and Health Administration ceiling value standard for workplace air is 50 ppm.15
On September 11, 1974, the National Institute for Occupational Safety and Health transmitted criteria for a recommended standard on chloroform to the Department of Labor, NIOSH’s recommendations included that no worker be exposed to chloroform in excess of 10 ppm determined as a time-weighted average exposure for up to a 10-hour workday, 40-hour work week, or for any 10-minute period to more than 50 ppm.10
Epidemiologic Studies
The Division of Surveillance, Hazard Evaluations, and Field Studies, NIOSH, is planning to conduct environmental and mortality studies in industries in which people are exposed to chloroform. Efforts are now in progress to identify worker populations at risk of chloroform exposures for epidemiologic study.

**TABLE 1** Domestic Manufacturers and Producers of Chloroform
Domestic Manufacturers and Producers of Chloroform
Manufacturers and Producers
AddressAllied Chemical Corporation
Specialty Chemicals Division
Moundsville, West VirginiaDiamond Shamrock Corporation
Diamond Shamrock Chemical Company
Electro Chemicals Division
Belle, West VirginiaDow Chemical U.S.A.
Freeport, Texas
Plaquemine, LouisianaE.I. DuPont de Nemours & Company, Inc.
Industrial Chemicals Department
Niagara Falls, New YorkStauffer Chemical Company
Industrial Chemical Division
Louisville, KentuckyVulcan Materials Company
Chemicals Division
Newark, New Jersey
Wichita, Kansas
Geismar, LouisianaAdapted From:
1975 Directory of Chemical Producers, United States of America, Stanford Research Institute, Menlo Park, California, 1975, p. 478.
Synthetic Organic Chemicals, U.S. Production and Sales, 1973, U.S. International Trade Commission, ITC Publication 728, Washington, D.C., 1975, p. 231.

**TABLE 2** Domestic Distribution of Chloroform
Domestic Distribution of Chloroform
Distributors
Headquarters AddressAldrich Chemical Co., Inc.
940 W. St. Paul Avenue
Milwaukee, WI 53233Allied Chemical
Morristown, NJ 07960American Drug & Chemical Co.
3555 Hayden Avenue
Culver City, CA 90230Analabs, Inc.
Sub. New England Nuclear
80 Republic Drive
North Haven, CT 06473Apache Chemicals, Inc.
P.O. Box 126
Seward, IL 61077Ashland Chemical Company
Industrial Chemicals & Solvents
Division
Box 2219
Columbus, OH 43216J.T. Baker Chemical Co.
Phillipsburg, NJ 08865Bayside Research Corp.
P.O. Box 630146
Miami, FL 33163Bodman Chemicals
P.O. Box 500
Media, PA 19063Burdick & Jackson Laboratories, Inc.
1953 South Harvey Street
Muskegon, MI 49442Chemical Industries, Inc.
Box 991
Borger, TX 79007Chemical Samples Co.
P.O. Box 20305
Columbus, OH 43220Chem Service, Inc.
851 Lincoln Ave.
P.O. Box 194
West Chester, PA 19380Columbia Organic Chemical Co., Inc.
P.O. Box 9096
Columbia, SC 29290Diamond Shamrock Corp.
1100 Superior Ave.
Cleveland, OH 44114Dow Chemical Corp.
Barstow Bldg.,
2020 Dow Center
Midland, MI 48640EM Laboratories, Inc.
500 Executive Blvd.
Elmsford, NY 10523Eastern Chemical
Div. of Guardian Chemical Corp.
230 Marcus Blvd.
Hauppauge, NY 11787Eastman Organic Chemicals
Eastman Kodak Company
Rochester, NY 14650Fisher Scientific Co.
711 Forbes Avenue
Pittsburgh, PA 15219Gallard Schlesinger Chemical
Manufacturing Corporation
584 Mineola Avenue
Carle Place, NY 11514Great Lakes Terminal & Transport
1750 North Kingsbury St.
Chicago, IL 60614J.F. Henry Chemical Co.
Industrial and Fine Chemicals
245 Park Avenue
East Rutherford, NJ 07073I.C.N.-K&K
Life Sciences Group
121 Express Street
Plainview, NY 11803I.C.N. Pharmaceuticals, Inc.
Life Sciences Group
2727 Campus Drive
Irvine, Cal 92664Intsel Corp.
825 Third Avenue
New York, NY 10022Isotope Labeling Corp.
P.O. Box 838
Teaneck, NJ 07666MC & B Manufacturing Chemists
2909 Highland Avenue
Cincinnati, OH 45212Mallinckrodt, Inc.
2nd & Mallinckrodt Street
St. Louis, MO 63160Merck & Company, Inc.
Merck Chemical Division
Rahway, NJ 07065Miles Laboratories, Inc.
Research Products
R 700, 1127 Myrtle Street
Elkhart, IN 46514New England Nuclear
549 Albany Street
Boston, MA 02118Norell Chemical Co., Inc.
Arbor Avenue and Clara Street
Landisville, NJ 08326Ruger Chemical Company
P.O. Box 806
Hillside, NJ 07295Simmler and Son, Inc.
3755 Forest Park Avenue
St. Louis, MO 63108G. Frederick Smith Chemical Co.
867 McKinley Avenue
Columbus, OH 43223Stauffer Chemical Company
Industrial Chemical Division
Westport, CT 06880Tridom Chemical, Inc.
255 Oser Avenue
Hauppauge, NY 11787Joseph Turner & Company
Ridgefield, NJ 07657Union Oil Company of California
Amsco Division
3100 S. Meacham Road
Palatine, IL 60067VWR Scientific
Box 3200
San Francisco, CA 94119Vulcan Materials Company
Chemical Division
P.O. Box 545
Wichita, KS 67201Adapted from: Chem. Sources U.S.A., 1976 Edition, Directories Publishing Company, Flemington, New Jersey.
References
Carcinogenesis Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Report on Carcinogenesis Bioassay of Chloroform. March 1, 1976.
Number not used.
Synthetic Organic Chemicals, United States Production and Sales of Miscellaneous Chemicals, 1974. Preliminary, United States International Trade Commission, Washington, D.C., p. 9, January 1976.
Number not used.
Hardie, D.W.F. in Kirk-Othmer Encyclopedia of Chemical Technology, Second Edition. Interscience Publishers, New York, New York, Volume 5, pp. 119-127, 1964.
Lehmann, K.B. and Hasegawa. Studies of the absorption of chlorinated hydrocarbons in animals and humans. Arch. Hyg., 72:327-42, 1910.
Lehmann, K.B. and Schmidt-Kehl, L. The thirteen most important chlorinated aliphatic hydrocarbons from the standpoint of industrial hygiene. Arch. Hyg., 116:131-200, 1936.
Heilbrunn, G., Liebert, E., Szanto, P.B. Chronic chloroform poisoning — Clinical and pathological report of a case. Arch. Neurol. Psych., 53:68-72, 1945.
Bomski, H., Sobolewska, A., and Strakowski, A. Toxic damage of the liver by chloroform in chemical industry workers. Arch. Gewerbepathol. Gewerbehyg., 24:127-34, 1967.
U.S. DHEW/PHS/CDC/NIOSH. Criteria Document: Recomendations for an occupational exposure standard to chloroform. HEW (NIOSH), 75-114, 1974
Challen, P.J.R., Hickish, D.E., Bedford, J. Chronic chloroform intoxication. Br. J. Ind. Med., 15:243-49, 1958.
Fuhner, H. The intensity and action of chloroform and carbon tetrachloride. Arch. Exp. Pathol., 97:86-112, 1923.
Whipple, G.H. and Sperry, J.A. Chloroform poisoning — Liver necrosis and repair. Bull. Johns Hopkins Hospital, 20:278-89, 1909.
Eschenbrenner, A.B. Induction of hepatomas in mice by repeat oral administration of chloroform, with observations on sex differences. J. Nat’l. Cancer Inst., 5:251-55, 1945.
Federal Register. Vol. 39, No. 125 PartII, page 23451, June 27, 1974.
Number not used.
							
					
							Last Reviewed:  June 6, 2014						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Error processing SSI file  Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue